Renaissance Technologies LLC Increases Holdings in LifeStance Health Group, Inc. (NASDAQ:LFST)

Renaissance Technologies LLC increased its stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 421.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 612,800 shares of the company's stock after acquiring an additional 495,300 shares during the quarter. Renaissance Technologies LLC owned about 0.16% of LifeStance Health Group worth $4,516,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the stock. Jennison Associates LLC grew its position in shares of LifeStance Health Group by 278.4% during the fourth quarter. Jennison Associates LLC now owns 8,086,380 shares of the company's stock valued at $59,597,000 after purchasing an additional 5,949,438 shares in the last quarter. Vanguard Group Inc. grew its holdings in LifeStance Health Group by 7.9% during the 4th quarter. Vanguard Group Inc. now owns 10,689,396 shares of the company's stock valued at $78,781,000 after buying an additional 784,818 shares in the last quarter. Geode Capital Management LLC increased its stake in LifeStance Health Group by 26.8% in the 3rd quarter. Geode Capital Management LLC now owns 3,452,178 shares of the company's stock worth $24,170,000 after acquiring an additional 729,794 shares during the last quarter. First Eagle Investment Management LLC raised its holdings in shares of LifeStance Health Group by 182.8% during the 4th quarter. First Eagle Investment Management LLC now owns 785,666 shares of the company's stock worth $5,790,000 after acquiring an additional 507,826 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its position in shares of LifeStance Health Group by 507.8% during the 4th quarter. JPMorgan Chase & Co. now owns 575,154 shares of the company's stock valued at $4,239,000 after acquiring an additional 480,518 shares during the last quarter. 85.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have commented on LFST shares. William Blair reiterated an "outperform" rating on shares of LifeStance Health Group in a research report on Friday, February 28th. KeyCorp started coverage on LifeStance Health Group in a research report on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 price target for the company. Finally, Canaccord Genuity Group started coverage on LifeStance Health Group in a research note on Thursday, April 3rd. They set a "buy" rating and a $8.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $8.30.

Insider Buying and Selling

In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of the stock in a transaction on Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the sale, the insider now owns 339,810 shares in the company, valued at $2,344,689. This trade represents a 5.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 6.60% of the stock is owned by corporate insiders.

LifeStance Health Group Trading Up 0.6 %

NASDAQ LFST traded up $0.04 during trading on Friday, hitting $6.53. The stock had a trading volume of 934,051 shares, compared to its average volume of 1,615,301. The stock has a market capitalization of $2.51 billion, a price-to-earnings ratio of -25.12 and a beta of 1.30. The stock has a 50 day simple moving average of $6.99 and a 200 day simple moving average of $7.31. LifeStance Health Group, Inc. has a one year low of $4.64 and a one year high of $8.61. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.